IBC2:XETRA:XETRA-iShares II Public Limited Company - iShares $ High Yield Corporate Bond UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 4.0409

Change

0.00 (0.00)%

Market Cap

USD 0.28B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

N/A

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.07%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.02 (-0.06%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.02 (-0.07%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.38%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.60 (-0.39%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+1.34 (+0.95%)

USD 105.05B
JARI:XETRA Amundi Index Solutions - Amund..

+0.24 (+0.56%)

USD 102.57B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.03 (+0.06%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.52 (+0.10%)

USD 80.38B

ETFs Containing IBC2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.79% 32% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.79% 32% F 36% F
Trailing 12 Months  
Capital Gain 1.00% 22% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.00% 21% F 29% F
Trailing 5 Years  
Capital Gain -19.09% 9% A- 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.09% 9% A- 16% F
Average Annual (5 Year Horizon)  
Capital Gain -4.25% 13% F 16% F
Dividend Return -4.25% 12% F 15% F
Total Return N/A 41% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 6.77% 75% C 80% B-
Risk Adjusted Return -62.71% 11% F 10% F
Market Capitalization 0.28B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.